haidut

Member
Forum Supporter
Joined
Mar 18, 2013
Messages
19,798
Location
USA / Europe
This is the latest of a number of studies over the last year or so that point the finger at fat (and not sugar) as the primary factor in tumor growth. I posted a few studies in the past showing that tumor cells are highly dependent on fat for growth and proliferation, and a number of hypolipidemic agents like orlistat or even niacinamide can help curb, or even completely reverse tumor growth. In combination with a fatty acid oxidation inhibitor like Mildronate, the effect will probably be even more potent. And adding a fatty acid synthase (FAS) inhibitor like vitamin D or aspirin on top of that can create a well-rounded cancer treatment for most cancer types.
Cancer Cells Addicted To Fat And Use Fat Oxidation For Survival
Achilles Heel Of Cancer Found - Its Addiction To Fat
Niacinamide Can Cure Liver (and Maybe Pancreatic) Cancer
This study adds to the evidence for the role dietary fat and diet-induced ketogenesis in the progression of tumors. Interestingly, just like the study on liver and pancreatic cancer I posted just a few days ago, administering niacin was very effective as an anti-cancer agent. Ray has written quite a bit about the tendency of cancer patients to fall into ketosis, and this study confirms his statements. Niacin lowered the levels of acetoacetate (a biomarker of ketosis) and greatly inhibited tumor growth. The HED of nacin was about 15mg/kg and treatment was for 3.5 weeks. For the record, niacinamide is even more effective than niacin in interrupting ketosis, so using niacinamide at that dose would probably achieve even better results. Interestingly, this same dose of about 1.5g niacinamide daily was successfully used to improve type II diabetes in human trials and in animal trials it basically reversed the condition. I doubt these findings are just a coincidence given the link between lipolysis, ketogenesis, diabetes, and cancer.
As the study says, while the study only focused on one type of cancer (and its mutation), the morale of the story is that high-fat, low-carb diets are probably not good for cancer patients. Fasting also accelerated tumor growth, due to the increase in ketogenesis. Finally, the ketone acetoacetone not only served as fuel for the tumors but also had genomic/receptor effects, which also promoted tumor growth.

https://www.sciencedaily.com/releases/2017/01/170112141359.htm
"...Cancer cells love glucose, so a high-fat, low-carb diet should starve them, right? Not cancers driven by a notorious melanoma mutation. Research in mice suggests that cancers with BRAF V600E will grow faster in response to a high-fat 'ketogenic' diet. In addition, lipid-lowering agents such as statins curb these cancers' growth, even in the context of a more normal diet."

"...Most cancer cells display enhanced glucose uptake, a phenomenon known as the Warburg effect. A low-carb diet has been tried as a clinical countermeasure in a limited way, mainly in brain cancer. In contrast, a possible implication of the Winship researchers' results is that people fighting a cancer with a BRAF V600E mutation should avoid low-carb diets."

"...One of the alternative energy sources produced by ketogenesis is acetoacetate. Within cancer cells with the V600E mutation, acetoacetate production is stimulated, the Winship researchers had found. On top of that, acetoacetate binds the mutated B-raf protein and promotes its oncogenic activity, forming a cycle of positive feedback.

"...The Winship researchers wanted to test whether V600E cancer cells would respond to external acetoacetate. A ketogenic diet with very low carbohydrates, like an Atkins diet, can cause acetoacetate levels in the body to rise. Fasting can also trigger the same effect. Lipid-lowering agents commonly used to treat high cholesterol, such as statins (in this case, fluvastatin), niacin and fenofibrate, could slow the expansion of V600E tumors in mice, even when they were fed a normal diet. Those drugs reduced acetoacetate levels, and when the researchers injected acetoacetate to compensate, tumor growth sped up again."


http://www.cell.com/cell-metabolism/abstract/S1550-4131(16)30643-X
"...We chose three drugs that are clinically used to treat hypercholesterolemia: fluvastatin, which belongs to a class of cholesterol-lowering statins that are HMG-CoA reductase inhibitors (Avis et al., 2007); niacin (a.k.a. vitamin B3), which lowers triglycerides and is also clinically used to treat cardiovascular patients not taking a statin (Jacobson et al., 1994); and fenofibrate, a fibric acid derivative that also lowers triglycerides (Superko, 1989). We found that fluvastatin and niacin treatment effectively attenuated tumor growth potential of BRAF V600E-expressing A375 cells in xenograft mice; this could be reversed by intraperitoneal injection with acetoacetate (Figures 3A, top, and S4A, left)...Consistent with these findings, treatment with fluvastatin, niacin, or fenofibrate resulted in reduced serum levels of acetoacetate, but not b-hydroxybutyrate, in mice (Figures 3B and 3C, respectively), while acetoacetate injection rescued the decreased serum acetoacetate levels but did not affect 3HB levels."

"...We next sought to determine whether functional inhibition of acetoacetate would attenuate BRAF V600E tumor growth. We examined a group of commercially available acetoacetate analogs and found that dehydroacetic acid (DHAA) (Figure 4A) is an inhibitory homolog of acetoacetate."
"...Consistent with these findings, DHAA treatment for 3.5 weeks effectively inhibited tumor growth rates, sizes, and masses in nude mice with BRAF V600E-expressing human melanoma A2058 and A375 cell xenografts, but not in mice carrying control xenografts derived from HMCB cells expressing NRAS Q61K (Figures 6A and S6A)."
"...DHAA is a synthetic organic compound that is used mostly as a fungicide and bactericide (Stedman et al., 1954); it shows little to no clinical toxicity or irritating potential and has been safely used in skin-care products. Consistently, chronic injection of DHAA to nude mice for 4 weeks revealed that 200 mg/kg/day administered intraperitoneally is a well-tolerated dose that did not cause notable differences in histopathological analyses and weights of diverse organs (Figures S6C and S6D, respectively). Moreover, chronic treatment with DHAA had no obvious effect on the mouse gut microbiome, as evidenced by an unaltered total-DNA amount extracted from bacteria in mouse feces; this suggested no change in total bacterial number in the mouse gut (Figure S6E), and by altered proportions but no loss of any components of the gut microbiota (Figure S6F). DHAA treatment did not alter complete blood counts (CBC) or hematopoietic properties in representative A375 xenograft mice compared to the water-treated group (Table S1). These results together suggest that DHAA treatment does not cause obvious toxicity in vivo."
"...Further studies revealed that the inhibitory effect of DHAA treatment on tumor growth potential of A375 cells in xenograft mice was not reversed by intraperitoneal injection with acetoacetate (Figure 6G) despite increased serum levels of acetoacetate in DHAA-treated mice that received acetoacetate injection (Figure 6H). DHAA treatment did not affect serum levels of 3HB, cholesterol, or glucose in mice in either the presence or the absence of acetoacetate injection (Figures 6I, 6J, and S6G, respectively). Consistently, acetoacetate injection did not reverse the inhibitory effects of DHAA on phosphorylation of MEK1 and ERK1/2 (Figure 6K), BRAF V600E-MEK1 binding (Figure 6L), or cell proliferation rates assessed by IHC staining of Ki67 (Figures 6M and S6H) in tumors derived from A375 cells in mice. These data are consistent with previous results (Figures 5D–5E, 5I, and S5C) showing that acetoacetate was insufficient to reverse the effect of DHAA on BRAF V600E-expressing cells."
"...Consistent with our findings presented above, we found that treatment with a high-fat diet promoted—while DHAA alone inhibited—tumor growth rates, sizes, and masses in nude mice with BRAF V600E-expressing A2058 or A375 cell xenografts; co-treatment with DHAA effectively reversed the enhanced tumor growth potential of A2058 or A375 cells in xenograft mice fed with a high-fat diet (Figures 7A and S7A)."


An interesting side note from the above study is the use of a functional antagonist to acetoacetate instead of inhibiting its synthesis with niacin/niacinamide. The functional inhibitor used was dehydroacetic acid (DHAA) and it was very effective in curbing tumor growth when used in the same doses as niacin - i.e. HED of 15mg/kg. What is more important, just like niacin / niacinamide, DHAA was able to curb tumor growth even in the presence of high-fat diet and even injecting additional acetoacetate was not able to reverse the beneficial effect of DHAA. Given that DHAA is widely used and has very well-known safety profile (unlike orlistat), and is cheaply available as OTC chemical / supplement it could become one of the alternatives for people who cannot get access to other chemical like mildronate or want to potentiate the effects of niacinamide.
Dehydroacetic acid - Wikipedia
 
Last edited:

Lucenzo01

Member
Joined
May 17, 2016
Messages
355
Really interesting, thank you Haidut. Are you aware of Abraham Hoffer's work? He used to give his patients high doses of niacin with great results. He also used niacinamide some times, but he believed niacin was better. In the context of this study he could be right: niacin normalize blood cholesterol and niacinamide don't.
 
OP
haidut

haidut

Member
Forum Supporter
Joined
Mar 18, 2013
Messages
19,798
Location
USA / Europe
Really interesting, thank you Haidut. Are you aware of Abraham Hoffer's work? He used to give his patients high doses of niacin with great results. He also used niacinamide some times, but he believed niacin was better. In the context of this study he could be right: niacin normalize blood cholesterol and niacinamide don't.

Yes, I am familiar with his work and Peat quotes him a few times. Niacinamide is still probably better as it does not liberate histamine. Also increase in HDL from ingesting something (niacin) is generally not a good sign while niacinamide does not have this effect. Finally, niacinamide is a SIRT inhibitor, which has many good effects while niacin is not.
 

Addie1970

New Member
Joined
Jun 19, 2014
Messages
4
Good info Haidut,as always,thank you.
It sounds like if one has cancer, and especially melanoma, they should limit their consumption of even the good saturated fats like coconut oil,"real butter" etc.
 
OP
haidut

haidut

Member
Forum Supporter
Joined
Mar 18, 2013
Messages
19,798
Location
USA / Europe
Good info Haidut,as always,thank you.
It sounds like if one has cancer, and especially melanoma, they should limit their consumption of even the good saturated fats like coconut oil,"real butter" etc.

Actually, eating saturated fat has a quieting effect on cancer cells due to the signalling effects of that saturated fat. Also, the inflammation that also drives cancer growth and metastases depends on PUFA. So, by displacing PUFA from the cell saturated fat reduces that inflammatory burden and may retard cancer growth.
Using substances that limit fat oxidation or lipolysis is also an option of course. Speaking of which, I just posted another thread showing yet another type of aggressive cancer depends on fat for growth, metastases and survival.
Triple-Negative Breast Cancers Depend On Fat As Fuel
 

Ideonaut

Member
Joined
Sep 20, 2015
Messages
499
Location
Seattle
This is the latest of a number of studies over the last year or so that point the finger at fat (and not sugar) as the primary factor in tumor growth. I posted a few studies in the past showing that tumor cells are highly dependent on fat for growth and proliferation, and a number of hypolipidemic agents like orlistat or even niacinamide can help curb, or even completely reverse tumor growth. In combination with a fatty acid oxidation inhibitor like Mildronate, the effect will probably be even more potent. And adding a fatty acid synthase (FAS) inhibitor like vitamin D or aspirin on top of that can create a well-rounded cancer treatment for most cancer types.
Cancer Cells Addicted To Fat And Use Fat Oxidation For Survival
Achilles Heel Of Cancer Found - Its Addiction To Fat
Niacinamide Can Cure Liver (and Maybe Pancreatic) Cancer
This study adds to the evidence for the role dietary fat and diet-induced ketogenesis in the progression of tumors. Interestingly, just like the study on liver and pancreatic cancer I posted just a few days ago, administering niacin was very effective as an anti-cancer agent. Ray has written quite a bit about the tendency of cancer patients to fall into ketosis, and this study confirms his statements. Niacin lowered the levels of acetoacetate (a biomarker of ketosis) and greatly inhibited tumor growth. The HED of nacin was about 15mg/kg and treatment was for 3.5 weeks. For the record, niacinamide is even more effective than niacin in interrupting ketosis, so using niacinamide at that dose would probably achieve even better results. Interestingly, this same dose of about 1.5g niacinamide daily was successfully used to improve type II diabetes in human trials and in animal trials it basically reversed the condition. I doubt these findings are just a coincidence given the link between lipolysis, ketogenesis, diabetes, and cancer.
As the study says, while the study only focused on one type of cancer (and its mutation), the morale of the story is that high-fat, low-carb diets are probably not good for cancer patients. Fasting also accelerated tumor growth, due to the increase in ketogenesis. Finally, the ketone acetoacetone not only served as fuel for the tumors but also had genomic/receptor effects, which also promoted tumor growth.

https://www.sciencedaily.com/releases/2017/01/170112141359.htm
"...Cancer cells love glucose, so a high-fat, low-carb diet should starve them, right? Not cancers driven by a notorious melanoma mutation. Research in mice suggests that cancers with BRAF V600E will grow faster in response to a high-fat 'ketogenic' diet. In addition, lipid-lowering agents such as statins curb these cancers' growth, even in the context of a more normal diet."

"...Most cancer cells display enhanced glucose uptake, a phenomenon known as the Warburg effect. A low-carb diet has been tried as a clinical countermeasure in a limited way, mainly in brain cancer. In contrast, a possible implication of the Winship researchers' results is that people fighting a cancer with a BRAF V600E mutation should avoid low-carb diets."

"...One of the alternative energy sources produced by ketogenesis is acetoacetate. Within cancer cells with the V600E mutation, acetoacetate production is stimulated, the Winship researchers had found. On top of that, acetoacetate binds the mutated B-raf protein and promotes its oncogenic activity, forming a cycle of positive feedback.

"...The Winship researchers wanted to test whether V600E cancer cells would respond to external acetoacetate. A ketogenic diet with very low carbohydrates, like an Atkins diet, can cause acetoacetate levels in the body to rise. Fasting can also trigger the same effect. Lipid-lowering agents commonly used to treat high cholesterol, such as statins (in this case, fluvastatin), niacin and fenofibrate, could slow the expansion of V600E tumors in mice, even when they were fed a normal diet. Those drugs reduced acetoacetate levels, and when the researchers injected acetoacetate to compensate, tumor growth sped up again."


http://www.cell.com/cell-metabolism/abstract/S1550-4131(16)30643-X
"...We chose three drugs that are clinically used to treat hypercholesterolemia: fluvastatin, which belongs to a class of cholesterol-lowering statins that are HMG-CoA reductase inhibitors (Avis et al., 2007); niacin (a.k.a. vitamin B3), which lowers triglycerides and is also clinically used to treat cardiovascular patients not taking a statin (Jacobson et al., 1994); and fenofibrate, a fibric acid derivative that also lowers triglycerides (Superko, 1989). We found that fluvastatin and niacin treatment effectively attenuated tumor growth potential of BRAF V600E-expressing A375 cells in xenograft mice; this could be reversed by intraperitoneal injection with acetoacetate (Figures 3A, top, and S4A, left)...Consistent with these findings, treatment with fluvastatin, niacin, or fenofibrate resulted in reduced serum levels of acetoacetate, but not b-hydroxybutyrate, in mice (Figures 3B and 3C, respectively), while acetoacetate injection rescued the decreased serum acetoacetate levels but did not affect 3HB levels."

"...We next sought to determine whether functional inhibition of acetoacetate would attenuate BRAF V600E tumor growth. We examined a group of commercially available acetoacetate analogs and found that dehydroacetic acid (DHAA) (Figure 4A) is an inhibitory homolog of acetoacetate."
"...Consistent with these findings, DHAA treatment for 3.5 weeks effectively inhibited tumor growth rates, sizes, and masses in nude mice with BRAF V600E-expressing human melanoma A2058 and A375 cell xenografts, but not in mice carrying control xenografts derived from HMCB cells expressing NRAS Q61K (Figures 6A and S6A)."
"...DHAA is a synthetic organic compound that is used mostly as a fungicide and bactericide (Stedman et al., 1954); it shows little to no clinical toxicity or irritating potential and has been safely used in skin-care products. Consistently, chronic injection of DHAA to nude mice for 4 weeks revealed that 200 mg/kg/day administered intraperitoneally is a well-tolerated dose that did not cause notable differences in histopathological analyses and weights of diverse organs (Figures S6C and S6D, respectively). Moreover, chronic treatment with DHAA had no obvious effect on the mouse gut microbiome, as evidenced by an unaltered total-DNA amount extracted from bacteria in mouse feces; this suggested no change in total bacterial number in the mouse gut (Figure S6E), and by altered proportions but no loss of any components of the gut microbiota (Figure S6F). DHAA treatment did not alter complete blood counts (CBC) or hematopoietic properties in representative A375 xenograft mice compared to the water-treated group (Table S1). These results together suggest that DHAA treatment does not cause obvious toxicity in vivo."
"...Further studies revealed that the inhibitory effect of DHAA treatment on tumor growth potential of A375 cells in xenograft mice was not reversed by intraperitoneal injection with acetoacetate (Figure 6G) despite increased serum levels of acetoacetate in DHAA-treated mice that received acetoacetate injection (Figure 6H). DHAA treatment did not affect serum levels of 3HB, cholesterol, or glucose in mice in either the presence or the absence of acetoacetate injection (Figures 6I, 6J, and S6G, respectively). Consistently, acetoacetate injection did not reverse the inhibitory effects of DHAA on phosphorylation of MEK1 and ERK1/2 (Figure 6K), BRAF V600E-MEK1 binding (Figure 6L), or cell proliferation rates assessed by IHC staining of Ki67 (Figures 6M and S6H) in tumors derived from A375 cells in mice. These data are consistent with previous results (Figures 5D–5E, 5I, and S5C) showing that acetoacetate was insufficient to reverse the effect of DHAA on BRAF V600E-expressing cells."
"...Consistent with our findings presented above, we found that treatment with a high-fat diet promoted—while DHAA alone inhibited—tumor growth rates, sizes, and masses in nude mice with BRAF V600E-expressing A2058 or A375 cell xenografts; co-treatment with DHAA effectively reversed the enhanced tumor growth potential of A2058 or A375 cells in xenograft mice fed with a high-fat diet (Figures 7A and S7A)."


An interesting side note from the above study is the use of a functional antagonist to acetoacetate instead of inhibiting its synthesis with niacin/niacinamide. The functional inhibitor used was dehydroacetic acid (DHAA) and it was very effective in curbing tumor growth when used in the same doses as niacin - i.e. HED of 15mg/kg. What is more important, just like niacin / niacinamide, DHAA was able to curb tumor growth even in the presence of high-fat diet and even injecting additional acetoacetate was not able to reverse the beneficial effect of DHAA. Given that DHAA is widely used and has very well-known safety profile (unlike orlistat), and is cheaply available as OTC chemical / supplement it could become one of the alternatives for people who cannot get access to other chemical like mildronate or want to potentiate the effects of niacinamide.
Dehydroacetic acid - Wikipedia
Nice. Any sources for DHAA?
 
OP
haidut

haidut

Member
Forum Supporter
Joined
Mar 18, 2013
Messages
19,798
Location
USA / Europe

Koveras

Member
Joined
Dec 17, 2015
Messages
720
Another one @haidut and @Obi-wan might find interesting

Flipping the switch: Dietary fat, changes in fat metabolism may promote prostate cancer metastasis

When they compared the two types of tumor -- the localized ones lacking only the PTEN gene versus the metastatic tumors lacking both genes -- the researchers found that the metastatic tumors produced huge amounts of lipids, or fats. In tumors that lacked both PTEN and PML tumor suppressing genes, the cells' fat-production machinery was running amok.

"It was as though we'd found the tumors' lipogenic, or fat production, switch," said Pandolfi. "The implication is, if there's a switch, maybe there's a drug with which we can block this switch and maybe we can prevent metastasis or even cure metastatic prostate cancer," he added.

Such a drug already exists. Discovered in 2009, a molecule named "fatostatin" is currently being investigated for the treatment of obesity. Pandolfi and colleagues tested the molecule in lab mice. "The obesity drug blocked the lipogenesis fantastically and the tumors regressed and didn't metastasize."

In addition to opening the door to new treatment for metastatic prostate cancer, these findings also helped solve a long-standing scientific puzzle. For years, researchers had difficulty modeling metastatic prostate cancer in mice, making it hard to study the disease in the lab. Some speculated that mice simply weren't a good model for this particular disease. But the lipid production finding raised a question in Pandolfi's mind.

"I asked, 'What do our mice eat?'" Pandolfi recalled. It turned out, the mice ate a vegetable-based chow -- essentially a low-fat vegan diet that bore little resemblance to that of the average American male. When Pandolfi and colleagues increased the levels of saturated fats -- the kind found in fast food cheeseburgers and fries -- in the animals' diet, the mice developed aggressive, metastatic tumors.

Note that while Science Daily says "saturated fat" - the article says "Teklad Diet TD.06414" - or "37% saturated, 47% monounsaturated, 16% polyunsaturated." via lard and soybean oil.
 

Obi-wan

Member
Joined
Mar 16, 2017
Messages
1,120
Per @Travis linoleic acid causes proliferation. Stearic acid keeps arachidontate and linoleate from being incorporated into the cell membrane. L-threonine, selenomethionine, and beta-lapachone are anti-cancer.

stearic acid acts against linoleic acid
threonine acts against methionine
methylglyoxal disable's polyamines directly
beta-lapachone inhibits glyoxalase 1
selenomethionine inhibits polyamine synthesis

Manuka honey contains methylglyoxal. Beta-lapachone and threonine create methylglyoxal. Chocolate and Shea butter are high in stearic acid
 
OP
haidut

haidut

Member
Forum Supporter
Joined
Mar 18, 2013
Messages
19,798
Location
USA / Europe
Another one @haidut and @Obi-wan might find interesting

Flipping the switch: Dietary fat, changes in fat metabolism may promote prostate cancer metastasis

When they compared the two types of tumor -- the localized ones lacking only the PTEN gene versus the metastatic tumors lacking both genes -- the researchers found that the metastatic tumors produced huge amounts of lipids, or fats. In tumors that lacked both PTEN and PML tumor suppressing genes, the cells' fat-production machinery was running amok.

"It was as though we'd found the tumors' lipogenic, or fat production, switch," said Pandolfi. "The implication is, if there's a switch, maybe there's a drug with which we can block this switch and maybe we can prevent metastasis or even cure metastatic prostate cancer," he added.

Such a drug already exists. Discovered in 2009, a molecule named "fatostatin" is currently being investigated for the treatment of obesity. Pandolfi and colleagues tested the molecule in lab mice. "The obesity drug blocked the lipogenesis fantastically and the tumors regressed and didn't metastasize."

In addition to opening the door to new treatment for metastatic prostate cancer, these findings also helped solve a long-standing scientific puzzle. For years, researchers had difficulty modeling metastatic prostate cancer in mice, making it hard to study the disease in the lab. Some speculated that mice simply weren't a good model for this particular disease. But the lipid production finding raised a question in Pandolfi's mind.

"I asked, 'What do our mice eat?'" Pandolfi recalled. It turned out, the mice ate a vegetable-based chow -- essentially a low-fat vegan diet that bore little resemblance to that of the average American male. When Pandolfi and colleagues increased the levels of saturated fats -- the kind found in fast food cheeseburgers and fries -- in the animals' diet, the mice developed aggressive, metastatic tumors.

Note that while Science Daily says "saturated fat" - the article says "Teklad Diet TD.06414" - or "37% saturated, 47% monounsaturated, 16% polyunsaturated." via lard and soybean oil.

Thanks! This is another independent confirmation to Warburg's observation 80 years ago that cancer is not dependent on glucose for survival but cutting off its fat supply is usually deadly for the tumor cells. I guess it could really be that simple - certain fatty acids (PUFA) are the primary growth signal in the organism and removing them from the blood (or preferably tissues) tells the tumor to stop growing.
Lol, I love the name "fatostatin". Btw, it does not do anything plain old niacinamide or niacin can't do. In fact, it is a pyridine derivative (just like niacin/niacinamide) developed to mimic the effects of niacin without the flushing.
 

Obi-wan

Member
Joined
Mar 16, 2017
Messages
1,120
@haidut is the amount of niacinamide in energin enough?
 
B

Braveheart

Guest
This excellent post has caused me to review niacinamide....mon, this is some sort of wonder "drug"!!...for me, it's help w cancer, glaucoma, and melanoma is of special interest.
 
OP
haidut

haidut

Member
Forum Supporter
Joined
Mar 18, 2013
Messages
19,798
Location
USA / Europe
@haidut is the amount of niacinamide in energin enough?

It may need to be done twice a day for optimal effect. Ray has consistently recommended 50mg-100mg twice or thrice daily.
 

BibleBeliever

Member
Joined
Jul 27, 2016
Messages
403
Location
Canada
Per @Travis linoleic acid causes proliferation. Stearic acid keeps arachidontate and linoleate from being incorporated into the cell membrane. L-threonine, selenomethionine, and beta-lapachone are anti-cancer.

stearic acid acts against linoleic acid
threonine acts against methionine
methylglyoxal disable's polyamines directly
beta-lapachone inhibits glyoxalase 1
selenomethionine inhibits polyamine synthesis

Manuka honey contains methylglyoxal. Beta-lapachone and threonine create methylglyoxal. Chocolate and Shea butter are high in stearic acid

Since glycine acts against methionine, do you think when combined with beta-lapachone; pau d'arco or vitamin k2, that it creates methylglyoxal? I don't understand the mechanism of combining threonine and beta-lapchone, but I'm hoping glycine would produce the same effect. As when researching it is difficult to find anything other than manuka honey that naturally contains useful amounts of methylglyoxal.

Basically the cheap version of experimenting with your premise: combine butter (for stearic acid) with glycine and either pau d'arco or vitamin k2(mk4) and 1 brazil nut (selenmethionine) and in theory it would cause a strong anti-cancer effect?
 

coffee

New Member
Joined
Jul 17, 2019
Messages
3
Hello everyone. My husband's PSA jumped from 2 to 15 in one year. The doctor said that he is almost sure it is prostate cancer due to his family history (mom and dad died from cancer; brother had aggressive prostate cancer 2 years ago). He is doing MRI and biopsy soon, and he will follow anything that doctors say he needs to do. I will not be able to interfere in his decisions, but I think he would take the high dose niacinamide if there's no issues with that (side effects or interactions with traditional treatment).
@haidut @Obi-wan do you know if there's any side effects on trying the 1.5g of niacinamide daily for 3.5 weeks as the study suggests?

Any help in anything anyone think we should be trying is much appreciated. Thank you.
 

Similar threads

Back
Top Bottom